A Phase II Trial of Trisenox in Women With Recurrent or Metastatic Endometrial Adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- Acronyms NRR
- 13 Apr 2012 Actual patient number (5) added as reported by ClinicalTrials.gov.
- 13 Apr 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 04 Sep 2010 New trial record